ClinicalTrials.gg
CompletedNCT04463043Updated Sep 23, 2022

An App-based Versus a Web-based Self-management Intervention or Usual Care in People With Low Back and/or Neck Pain on a Waiting List for Hospital-based Outpatient Rehabilitation

An interventional study of SelfBACK app and e-Help webpage in Back Pain and Neck Pain, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-23.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
294
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of an individually tailored self-management intervention, the selfBACK app, in improving health status in patients on a waiting list for outpatient rehabilitation due to low back and/or neck pain compared to a non-tailored web-based self-management solution (e-Help) and usual care only.

Read the detailed description

Patients on waiting list for treatment at the multidisciplinary outpatient clinic for back, neck and shoulder rehabilitation, St. Olavs Hospital, Trondheim University Hospital, Norway, due to low back and/or neck pain are the target group for this study. The average waiting time for receiving treatment is 8-10 weeks. The use of digital solutions can be a beneficial approach to support self-management during the waiting period. Therefore, the effectiveness of these tools in this patients group needs to be evaluated.

A total of 279 participants will be recruited and randomly allocated to one of the three groups: 1) the selfBACK app in addition to usual care; 2) the e-Help webpage in addition to usual care; and 3) usual care only. Participants who receive either the selfBACK app and the e-Help webpage will be allowed to seek care, treatment or help elsewhere as usual.

Self-reported outcome measures will be collected through web-based questionnaires at three follow-up time points: 1) 6 weeks; 2) 3 months (primary endpoint); and 3) 6 months. In addition, participants receiving the selfBACK app will be asked a set of weekly tailoring questions to individualize self-management plans. Objective registry based data linked to social security number in Norway will be used to investigate health care consumption and sickness absence at 1 year (and up to 5 years).

02

Conditions studied

  • Back Pain
  • Neck Pain

Keywords

  • self-management
  • rehabilitation
  • mHealth
  • eHealth
03

In context

Back Pain

2,389 studies on the registry are indexed under Back Pain; 282 are open to participants now.

This study's enrollment of 294 is above the median of 60 across 1,952 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 494 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • On waiting list for treatment at the multidisciplinary outpatient clinic for back, neck and shoulder rehabilitation, St. Olavs Hospital, Trondheim University Hospital, Norway due to low back pain and/or neck pain
  • Own and use a smartphone with internet access to download the mobile application
  • Able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Less than 4 weeks waiting time until scheduled appointment at clinic (i.e., patients prioritized for urgent treatment/examination)
  • Unable to take part in exercise/physical activity, e.g. non-ambulatory patients, use of walking aids, unable to get up and down the floor independently
  • Unable to speak and/or read Norwegian
  • Unable to complete the baseline questionnaire
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
294 participants (actual)

Study arms

  • Experimental
    SelfBACK app

    The selfBACK app in addition to usual care

    Device: SelfBACK app · Other: Usual care

  • Active comparator
    e-Help webpage

    The e-Help webpage in addition to usual care

    Other: e-Help webpage · Other: Usual care

  • Active comparator
    Usual care

    Usual care only

    Other: Usual care

Interventions

  • DeviceSelfBACK app

    The selfBACK is an evidence-based and data-driven decision support system (DSS) to support self-management of low back and neck pain delivered via a smartphone app. The selfBACK app provides individually tailored self-management plans to participants on a weekly basis by matching the participant's health information with targeted educational messages, physical activity advices and exercise recommendations via the DSS.

  • Othere-Help webpage

    The e-Help is an evidence-based web-based resource to support self-management of low back and neck pain. The e-Help webpage provides evidence-based self-management content equivalent to the selfBACK including educational messages, physical activity and exercise recommendations. Instructions on how to compose exercise programs will be given to participants, however no tailored self-management support will be offered in this solution.

  • OtherUsual care

    Usual care refers to seeking care or receiving treatments or help as usual.

06

What researchers measure

Primary outcomes

  1. Musculoskeletal Health Questionnaire (MSK-HQ)

    The MSK-HQ is used to measure musculoskeletal health status. The MSK-HQ contains 14 items scored from 0 to 4. The final score ranges from 0 to 56 (sum of all items), with higher scores indicating better musculoskeletal health status.

    Time frame: Change from baseline to 3 months

Secondary outcomes

  1. Pain-related disability for low back pain

    Pain-related disability is measured by the Roland Morris Disability Questionnaire (RMDQ) ranging from 0 to 24. Higher scores indicate higher pain-related disability.

    Time frame: Change from baseline to 3 months

  2. Pain-related disability for neck pain

    Pain-related disability is measured by the Neck Disability Index (NDI) ranging from 0 to 50. Higher scores indicate higher pain-related disability.

    Time frame: Change from baseline to 3 months

  3. Average pain intensity

    The average pain intensity within the past week is measured by a 11-point numerical rating scale (NRS) ranging from 0='no pain' to 10='worst pain imaginable'.

    Time frame: Change from baseline to 3 months

  4. Worst pain intensity

    The worst pain intensity within the past week is measured by a 11-point numerical rating scale (NRS) ranging from 0='no pain' to 10='worst pain imaginable'.

    Time frame: Change from baseline to 3 months

  5. Health related quality of life

    The EuroQoL 5-dimension (EQ-5D) questionnaire is used to assess health-related quality of life. 5 items scored 0 - 5 plus visual analogue scale scored 0- 100.

    Time frame: Change from baseline to 3 months

  6. Pain self-efficacy

    The Pain Self-Efficacy Questionnaire (PSEQ) is used to assess participants' level of confidence in carrying out specific activities despite their pain. 10 items scored 0 - 6.

    Time frame: Change from baseline to 3 months

  7. Illness perception

    The Brief Illness Perception Questionnaire (BIPQ) is used to evaluate participants' illness perception. 8 items scored 0 - 10.

    Time frame: Change from baseline to 3 months

Other outcomes

  1. Fear avoidance belief

    The Fear-Avoidance Belief Questionnaire (FABQ) - physical activity subscale is used to measure participant's beliefs about how physical activity affect their low back and/or neck pain. 5 items scored 0 - 6

    Time frame: Change from baseline to 3 months

  2. Stress symptoms

    The Perceived Stress Scale (PSS) is used to evaluate stress levels. 10 items scored 0 - 4.

    Time frame: Change from baseline to 3 months

  3. Depressive symptoms

    The Patient Health Questionnaire-2 (PHQ-2) is used to evaluate patients' depressive symptoms. 2 items scored 0 - 3.

    Time frame: Change from baseline to 3 months

  4. Functional change

    The Patient Specific Functional Scale (PSFS) is used to evaluate changes in participant's ability to perform up to two self-selected activities regarded as important by them. Ability levels scored 0 - 10.

    Time frame: Change from baseline to 3 months

  5. Self-reported physical activity

    The modernised Saltin-Grimby Physical Activity Level Scale is used to evaluate self-reported leisure time physical activity. 1 item (4 options).

    Time frame: Change from baseline to 3 months

  6. Self-reported sleep

    Sleep problems are assessed by four self-report items which provide information needed to diagnose insomnia according to the DSM-V criteria. 4 items scored 0 - 2.

    Time frame: Change from baseline to 3 months

  7. Work ability

    Work ability index (WAI) is used to assess work ability. 1-item rated on an 11-point numeric rating scale (0='completely unable to work' to 10='work ability at its best').

    Time frame: Change from baseline to 3 months

  8. Satisfaction with intervention

    Patient Acceptable Symptom State (PASS) is used to determine if patients consider themselves well and, as such, are satisfied with the treatment. 1 item (yes/no)

    Time frame: 3 months

  9. Perceived effect

    Patient's Global Perceived Effect is used to investigate participants' perception of effect from the intervention they received. 1 item scored -5 to 5

    Time frame: 3 months

  10. Health care consumption

    Objective registry based data linked to social security number in Norway are used to investigate health care consumption.

    Time frame: 1 year

  11. Sickness absence

    Objective registry based data linked to social security number in Norway are used to investigate sickness absence.

    Time frame: 1 year

07

Study locations

1 site
  • Tverrfaglig poliklinikk rygg/nakke/skulder, St. Olavs Hospital
    Trondheim, Norway
08

References and documents

Publications

  • Marcuzzi A, Bach K, Nordstoga AL, Bertheussen GF, Ashikhmin I, Boldermo NO, Kvarner EN, Nilsen TIL, Marchand GH, Ose SO, Aasdahl L, Kaspersen SL, Bardal EM, Borke JB, Mork PJ, Gismervik S. Individually tailored self-management app-based intervention (selfBACK) versus a self-management web-based intervention (e-Help) or usual care in people with low back and neck pain referred to secondary care: protocol for a multiarm randomised clinical trial. BMJ Open. 2021 Sep 13;11(9):e047921. doi: 10.1136/bmjopen-2020-047921. PubMed 34518253 ↗
  • Marcuzzi A, Klevanger NE, Aasdahl L, Gismervik S, Bach K, Mork PJ, Nordstoga AL. An Artificial Intelligence-Based App for Self-Management of Low Back and Neck Pain in Specialist Care: Process Evaluation From a Randomized Clinical Trial. JMIR Hum Factors. 2024 Jul 9;11:e55716. doi: 10.2196/55716. PubMed 38980710 ↗
  • Marcuzzi A, Nordstoga AL, Bach K, Aasdahl L, Nilsen TIL, Bardal EM, Boldermo NO, Falkener Bertheussen G, Marchand GH, Gismervik S, Mork PJ. Effect of an Artificial Intelligence-Based Self-Management App on Musculoskeletal Health in Patients With Neck and/or Low Back Pain Referred to Specialist Care: A Randomized Clinical Trial. JAMA Netw Open. 2023 Jun 1;6(6):e2320400. doi: 10.1001/jamanetworkopen.2023.20400. PubMed 37368401 ↗

Individual participant data

Plan to share: Yes — Individual participant data will be available, including data dictionaries. Data available to share include individual participant data collected during the trial, after deidentification.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 5 years after end of trial and ending 30 years after end of trial.

Access criteria: Investigators whose proposed use of the data has been approved by the national ethics committee. Proposals should be directed to the principal investigator. To gain access, data requestors will need to sign a data access agreement. Information regarding submitting proposals and accessing data may be found at (Link will be provided after completing the trial).

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2020 to primary completion in Aug 2021, 12 months.

Of 933 non-industry interventional studies with no phase under Back Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's 12 months is above that.

Counting every sponsor, half of 997 studies reached it within 11 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2020
First posted
Jul 9, 2020
StartActual
Jul 9, 2020
Primary completionActual
Aug 1, 2021
CompletionActual
Dec 3, 2021
Last update
Sep 23, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04463043
Collaborators
St. Olavs Hospital
Responsible party
Sponsor
First posted
Jul 9, 2020
Start date
Jul 9, 2020
Primary completion
Aug 1, 2021
Completion
Dec 3, 2021
Last update
Sep 23, 2022

Study contacts

Siri Forsmo, phd prof
study director · Norwegian University of Science and Technology

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion